# Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism

> **NCT00788736** · — · COMPLETED · sponsor: **Ottawa Hospital Research Institute** · enrollment: 2537 (actual)

## Conditions studied

- Venous Thromboembolism

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00788736
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2016-09
- **Final completion:** 2016-10
- **Target enrollment:** 2537 (ACTUAL)
- **Last updated:** 2016-10-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00788736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00788736, "Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00788736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*